Prothena
PRTA
#7703
Rank
A$0.63 B
Marketcap
A$12.42
Share price
-2.14%
Change (1 day)
-19.82%
Change (1 year)

Earnings for Prothena (PRTA)

Earnings in 2026 (TTM): -A$90.54 Million

According to Prothena's latest financial reports the company's current earnings are A$54.53 Million. In 2025 the company made an earning of -A$0.28 Billion a decrease over its 2024 earnings that were of -A$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Prothena from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$90.54 Million-67.53%
2025 -A$0.28 Billion19.41%
2024 -A$0.24 Billion-19.09%
2023 -A$0.29 Billion45.21%
2022 -A$0.2 Billion-282.78%
2021 A$0.10 B-163.84%
2020 -A$0.18 Billion33.94%
2019 -A$0.13 Billion-44.78%
2018 -A$0.24 Billion-0.97%
2017 -A$0.24 Billion-3.33%
2016 -A$0.25 Billion99.17%
2015 -A$0.13 Billion1102.24%
2014 -A$10.05 Million-83.55%
2013 -A$61.08 Million-2.37%
2012 -A$62.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amarin Corporation
AMRN
-A$25.88 Million-71.39%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Alnylam Pharmaceuticals
ALNY
A$1.84 B-2,140.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
A$0.26 B-391.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland